Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria.
Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB. Malkin E, et al. Among authors: long ca. PLoS Clin Trials. 2007;2(4):e12. doi: 10.1371/journal.pctr.0020012. Epub 2007 Apr 6. PLoS Clin Trials. 2007. PMID: 17415408 Free PMC article.
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.
Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, MacDonald N, Narum DL, Long CA, Miller LH, Saul A, Mullen GE. Qian F, et al. Among authors: long ca. Vaccine. 2007 May 16;25(20):3923-33. doi: 10.1016/j.vaccine.2007.02.073. Epub 2007 Mar 13. Vaccine. 2007. PMID: 17428587 Free PMC article.
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP. Wu Y, et al. PLoS One. 2008 Jul 9;3(7):e2636. doi: 10.1371/journal.pone.0002636. PLoS One. 2008. PMID: 18612426 Free PMC article. Clinical Trial.
Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection.
Narum DL, Nguyen V, Zhang Y, Glen J, Shimp RL, Lambert L, Ling IT, Reiter K, Ogun SA, Long C, Holder AA, Herrera R. Narum DL, et al. Infect Immun. 2008 Nov;76(11):4876-82. doi: 10.1128/IAI.01717-07. Epub 2008 Aug 18. Infect Immun. 2008. PMID: 18710865 Free PMC article.
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure.
Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL Jr, Lambert L, Miller LH, Long CA, Saul A, Narum DL. Tsai CW, et al. Among authors: long ca. Mol Biochem Parasitol. 2009 Mar;164(1):45-56. doi: 10.1016/j.molbiopara.2008.11.006. Epub 2008 Nov 27. Mol Biochem Parasitol. 2009. PMID: 19073223 Free PMC article.
361 results